This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Healthy
and you are
between 21 and 55
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The overall aim of the study is to establish bioequivalence between commercial tofacitinib tablet formulations with the tofacitinib capsule formulation.

Provided treatments

  • Drug: tofacitinib 10 mg
  • Drug: tofacitinib 5 mg
Tris trial is registered with FDA with number: NCT01599377. The sponsor of the trial is Pfizer and it is looking for 50 volunteers for the current phase.
Official trial title:
Phase 1, Open-Label, Randomized, Single-Dose, Cross-Over, Bioequivalence Study Comparing Tablets (5 And 10 Mg) And Capsules (5 And 10 Mg) Of Tofacitinib Under Fasted Conditions In Healthy Volunteers